IO Biotech, Inc. (IOBTQ) Earnings
IO Biotech, Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Nov 14, 2025
From the latest earnings 8-K
Revenue • FY2024
$0
As reported
Diluted EPS • FY2024
-$1.45
▲ 26.8%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from IOBTQ's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2024 | $0 | -$95.49M | — | -$1.45 | -$82.39M | — | — |
| FY2023 | $0 | -$86.08M | — | -$1.98 | -$72.06M | — | — |
| FY2022 | $0 | -$71.46M | — | -$2.48 | -$60.42M | — | — |
| FY2021 | $0 | -$67.88M | — | -$17.30 | -$40.8M | — | — |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Nov 14, 2025 | 8-K (2.02) | 0001193125-25-281657EDGAR |
| Aug 14, 2025 | 8-K (2.02) | 0001193125-25-180830EDGAR |
| Aug 11, 2025 | 8-K (2.02) | 0001193125-25-177471EDGAR |
| May 14, 2025 | 8-K (2.02) | 0001193125-25-119406EDGAR |
| Mar 4, 2025 | 8-K (2.02) | 0001193125-25-045673EDGAR |
| Nov 12, 2024 | 8-K (2.02) | 0001193125-24-255127EDGAR |
| Aug 13, 2024 | 8-K (2.02) | 0001193125-24-199383EDGAR |
| May 14, 2024 | 8-K (2.02) | 0001193125-24-137754EDGAR |
Never miss a IOBTQ filing.
Get an email when IOBTQ files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.